Research is being conducted on the heterogeneity of cancer-associated fibroblasts and their role in cancer therapy. Studies are exploring the development, mechanisms, and therapeutic implications of tumor heterogeneity, as well as the potential for precision targeting strategies. The tumor microenvironment and interactions between cancer-associated fibroblasts and tumor cells are also being investigated for their impact on cancer therapy and potential therapeutic targets.